Overview

A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer

Status:
Withdrawn
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to measure ALA-induced fluorescence in both normal and malignant tissue.
Phase:
Phase 1
Details
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Treatments:
Aminolevulinic Acid